Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP930979.RApDsfyB2KsLq6I-hmXPYRTfqXAKljoggVOS4rlG0gkx0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP930979.RApDsfyB2KsLq6I-hmXPYRTfqXAKljoggVOS4rlG0gkx0130_assertion type Assertion NP930979.RApDsfyB2KsLq6I-hmXPYRTfqXAKljoggVOS4rlG0gkx0130_head.
- NP930979.RApDsfyB2KsLq6I-hmXPYRTfqXAKljoggVOS4rlG0gkx0130_assertion description "[Int-2 was amplified in 22% (96/440) of the primary breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP930979.RApDsfyB2KsLq6I-hmXPYRTfqXAKljoggVOS4rlG0gkx0130_provenance.
- NP930979.RApDsfyB2KsLq6I-hmXPYRTfqXAKljoggVOS4rlG0gkx0130_assertion evidence source_evidence_literature NP930979.RApDsfyB2KsLq6I-hmXPYRTfqXAKljoggVOS4rlG0gkx0130_provenance.
- NP930979.RApDsfyB2KsLq6I-hmXPYRTfqXAKljoggVOS4rlG0gkx0130_assertion SIO_000772 11445874 NP930979.RApDsfyB2KsLq6I-hmXPYRTfqXAKljoggVOS4rlG0gkx0130_provenance.
- NP930979.RApDsfyB2KsLq6I-hmXPYRTfqXAKljoggVOS4rlG0gkx0130_assertion wasDerivedFrom befree-20150227 NP930979.RApDsfyB2KsLq6I-hmXPYRTfqXAKljoggVOS4rlG0gkx0130_provenance.
- NP930979.RApDsfyB2KsLq6I-hmXPYRTfqXAKljoggVOS4rlG0gkx0130_assertion wasGeneratedBy ECO_0000203 NP930979.RApDsfyB2KsLq6I-hmXPYRTfqXAKljoggVOS4rlG0gkx0130_provenance.